Predictive performance of physiologically based kinetic (PBK) models based on in-silico/in vitro-in vivo extrapolation (IS/IVIVE)

被引：0
|
作者：
Kalra, P. [1 ]
Zhou, H. [1 ]
Lawless, M. [1 ]
机构：
[1] Simulat Plus, Lancaster, PA USA
来源：
TOXICOLOGY LETTERS | 2023年 / 384卷
关键词：
D O I：
暂无
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
P22-40
引用
收藏
页码：S259 / S260
页数：2
相关论文
共 50 条
  • [41] A Model Mechanism-Based Explanation of an In Vitro-In Vivo Disconnect for Improving Extrapolation and Translation
    Smith, Andrew K.
    Xu, Yanli
    Ropella, Glen E. P.
    Hunt, C. Anthony
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2018, 365 (01): : 127 - 138
  • [42] Fish Physiologically Based Toxicokinetic Modeling Approach for In Vitro-In Vivo and Cross-Species Extrapolation of Endocrine-Disrupting Chemicals in Risk Assessment
    Xie, Ruili
    Xu, Yiping
    Ma, Mei
    Wang, Zijian
    ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2024, 58 (08) : 3677 - 3689
  • [43] In silico resources to assist in the development and evaluation of physiologically-based kinetic models
    Madden J.C.
    Pawar G.
    Cronin M.T.D.
    Webb S.
    Tan Y.-M.
    Paini A.
    Computational Toxicology, 2019, 11 : 33 - 49
  • [44] Development of a predictive in vitro dissolution for clarithromycin granular suspension based on in vitro-in vivo correlations
    Alkhalidi, Bashar A.
    Al-Ghazawi, Mutasim
    AlKhatib, Hatim S.
    Sallam, AlSayed
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2010, 15 (03) : 286 - 295
  • [45] Next generation physiologically based kinetic (NG-PBK) models in support of regulatory decision making
    Paini A.
    Leonard J.A.
    Joossens E.
    Bessems J.G.M.
    Desalegn A.
    Dorne J.L.
    Gosling J.P.
    Heringa M.B.
    Klaric M.
    Kliment T.
    Kramer N.I.
    Loizou G.
    Louisse J.
    Lumen A.
    Madden J.C.
    Patterson E.A.
    Proença S.
    Punt A.
    Setzer R.W.
    Suciu N.
    Troutman J.
    Yoon M.
    Worth A.
    Tan Y.M.
    Computational Toxicology, 2019, 9 : 61 - 72
  • [46] Evaluation of an integrated in vitro-in silico PBPK (physiologically based pharmacokinetic) model to provide estimates of human bioavailability
    Cai, HL
    Stoner, C
    Reddy, A
    Freiwald, S
    Smith, D
    Winters, R
    Stankovic, C
    Surendran, N
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 308 (1-2) : 133 - 139
  • [47] Reply to "Comment on 'In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption Models'"
    Sjogren, Erik
    Thorn, Helena
    Tannergren, Christer
    MOLECULAR PHARMACEUTICS, 2017, 14 (01) : 340 - 343
  • [48] Comment on "In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically-Based Absorption Models"
    Turner, David B.
    Liu, Bo
    Patel, Nikunjkumar
    Pathak, Shriram M.
    Polak, Sebastian
    Jamei, Masoud
    Dressman, Jennifer
    Rostami-Hodjegan, Amin
    MOLECULAR PHARMACEUTICS, 2017, 14 (01) : 336 - 339
  • [49] Prediction of human cardiotoxicity of methadone by a combined in vitro - physiologically based kinetic (PBK) modelling- based reverse dosimetry approach
    Shi, M.
    Strikwold, M.
    Rietjens, I. M. C. M.
    Bouwmeester, H.
    TOXICOLOGY LETTERS, 2019, 314 : S154 - S154
  • [50] Integration of mechanism-based in vitro methods and quantitative in vitro-in vivo extrapolation (QIVIVE) modelling for prediction of nephrotoxicity
    Mally, A.
    Birk, B.
    DiFiore, S.
    Ellinger, B.
    Jarzina, S.
    Taverne, F.
    Kramer, N.
    TOXICOLOGY LETTERS, 2018, 295 : S27 - S27
12345